https://www.israelnationalnews.com/news/319067
Assuta Hospital in Ashdod has published a new groundbreaking research showing that the booster dose of the COVID-19 vaccine increases by 40 times the number of antibodies found in immunocompromised patients.
Recent research from around the world has shown a drop in the number of antibodies starting a few months after the second dose, alongside an extreme and encouraging rise following the administration of a booster dose in the general population.
The Assuta research shows that this data holds true for those who are immunocompromised as well.
No comments :
Post a Comment
ANONYMOUS COMMENTS WILL NOT BE POSTED!
please use either your real name or a pseudonym.